An analysis of Epithalon (AEDG tetrapeptide) in preclinical research contexts, covering telomerase activation via TERT upregulation, pineal gland signaling, and neuronal aging model findings.

Dihexa has been studied as an allosteric potentiator of HGF/c-Met receptor signaling, with preclinical models suggesting effects on dendritic spine density and hippocampal LTP, though significant evidence limitations arose from key retractions in 2025.

An analysis of Dihexa’s mechanism as an HGF hinge-region ligand, focusing on c-Met receptor activation, hippocampal dendritic spine density modulation, and synaptogenesis findings from preclinical animal models.

A research-context analysis of P21 peptide’s mechanism of action through LIF pathway partial inhibition, downstream STAT3 disinhibition of hippocampal dentate gyrus neurogenesis, and BDNF-TrkB signaling cross-talk in AD and Down syndrome preclinical models.

A research-context examination of Dihexa’s HGF/c-Met receptor agonism mechanism, its observed effects on hippocampal dendritic spine density and synaptogenesis in rodent models, and the significant translational limitations for human applications.

A research-context synthesis of current preclinical findings around Cerebrolysin and related biological systems, with explicit attention to study limitations.

← Back to The Cognitive Edge Compound Overview P21, also referred to in the literature as P021, is a tetrapeptide derived from a specific region of the ciliary neurotrophic factor (CNTF) sequence. CNTF is a full-length protein that belongs to the cytokine superfamily and has documented interactions with neurotrophin signaling infrastructure. The peptide fragment that […]

← Back to The Cognitive Edge Compound Overview: Research Context Only GHK-Cu is a copper-binding tripeptide, glycyl-L-histidyl-L-lysine, identified in biological matrices across research contexts. Its affinity for copper ions is what gives it biochemical relevance. The copper chelation is not incidental. It appears central to how the compound interacts with cellular signaling machinery. GHK-Cu is […]

← Back to The Cognitive Edge Dihexa is a synthetic peptidomimetic, meaning it is a small molecule engineered to mimic certain structural features of a peptide without being a full peptide chain. It was developed as a derivative of Nle1-angiotensin IV, itself an analog of angiotensin IV, a short signaling peptide most people associate with […]

← Back to The Cognitive Edge Research Overview Dihexa is a synthetic peptide that has attracted attention in neuroscience research circles over the past decade, primarily because of its proposed ability to amplify a signaling pathway that most researchers do not immediately associate with synaptogenesis. The compound is derived from angiotensin IV, but its mechanism […]